Exploring the association of blood hemoglobin concentration with peak oxygen uptake among WRA: A pilot study for the establishment of functional hemoglobin cut-off
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2026
Project Lead
Dr Venkatesh K, Dr Sucharita S et al
Authors
Dr Venkatesh K, Dr Sucharita S et al
Project Status
ongoing
Project Type
ICMR